drugset / Trial / NCT04997967

Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis

NCT04997967 ↗

Phase 4 Unknown 100 enrolled Assiut University
RandomizedParallel-groupOpen-labelHealth-services research

Summary

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a lengthy and uncomfortable procedure that requires adequate sedation. Propofol is the commonly used sedative during ERCP. However, dose dependent cardiac and respiratory depression may occur. Hypotension usually occurs in severe cholangitis which necessitate the use of alternative sedative. The aim is to study the efficacy and safety of ketofol as a sedative during urgent ERCP for severe cholangitis.

Timeline

Start
2020-07-01
Primary completion
2021-08
Completion
2021-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 2 mg/ml —
Comparator Propofol Small molecule 50 ug/kg Intravenous
Comparator Propofol Small molecule 0.5 mg/kg Intravenous
Comparator Propofol Small molecule 8 mg/ml Intravenous

Indications

No indication recorded.